These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 23945108

  • 1. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
    Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K.
    J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
    [Abstract] [Full Text] [Related]

  • 2. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P, García-Baquero R, Jia AY, Ocaña S, Alvarez-Múgica M, Alvarez-Ossorio JL, Cordon-Cardo C, Cava F, Sánchez-Carbayo M.
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [Abstract] [Full Text] [Related]

  • 3. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
    Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I.
    Int J Cancer; 2013 Jun 01; 132(11):2479-91. PubMed ID: 23169479
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.
    Cancer Genomics Proteomics; 2013 Jun 01; 10(3):93-113. PubMed ID: 23741026
    [Abstract] [Full Text] [Related]

  • 5. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH, Stier K, Weickmann S, Zhao Z, Buckendahl L, Stephan C, Kilic E, Jung K.
    Cancer Med; 2017 Oct 01; 6(10):2252-2262. PubMed ID: 28879675
    [Abstract] [Full Text] [Related]

  • 6. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B, Li J, Sun M, Sun L, Zhang X.
    IUBMB Life; 2014 May 01; 66(5):371-7. PubMed ID: 24846313
    [Abstract] [Full Text] [Related]

  • 7. Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer.
    Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS, Song PH, Choi YH, Kim IY, Moon SK, Kim WJ.
    Int J Oncol; 2012 Nov 01; 41(5):1871-8. PubMed ID: 22961325
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
    Lee H, Kim KR, Cho NH, Hong SR, Jeong H, Kwon SY, Park KH, An HJ, Kim TH, Kim I, Yoon HK, Suh KS, Min KO, Choi HJ, Park JY, Yoo CW, Lee YS, Lee HJ, Lee WS, Park CS, Lee Y, Gynecological Pathology Study Group of the Korean Society of Pathologists.
    World J Surg Oncol; 2014 Nov 08; 12():334. PubMed ID: 25381598
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R.
    Int J Cancer; 2013 Apr 01; 132(7):1633-45. PubMed ID: 22987275
    [Abstract] [Full Text] [Related]

  • 10. Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.
    Dip N, Reis ST, Timoszczuk LS, Viana NI, Piantino CB, Morais DR, Moura CM, Abe DK, Silva IA, Srougi M, Dall'Oglio MF, Leite KR.
    J Urol; 2012 Nov 01; 188(5):1951-6. PubMed ID: 22999546
    [Abstract] [Full Text] [Related]

  • 11. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T, Suzuki H, Nojima M, Kitamura H, Yamamoto E, Maruyama R, Ashida M, Hatahira T, Kai M, Masumori N, Tokino T, Imai K, Tsukamoto T, Toyota M.
    Eur Urol; 2013 Jun 01; 63(6):1091-100. PubMed ID: 23200812
    [Abstract] [Full Text] [Related]

  • 12. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L, Liu Y, Du L, Li J, Jiang X, Zheng G, Qu A, Wang H, Wang L, Zhang X, Liu H, Pan H, Yang Y, Wang C.
    Mol Med Rep; 2015 Jul 01; 12(1):615-22. PubMed ID: 25738263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of microRNAs in basal cell carcinoma.
    Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.
    Br J Dermatol; 2012 Oct 01; 167(4):847-55. PubMed ID: 22540308
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Jin N, Jin X, Gu X, Na W, Zhang M, Zhao R.
    Mol Med Rep; 2015 Aug 01; 12(2):3170-6. PubMed ID: 25955758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.